Daniel J Lodge

Associate Professor, Pharmacology

Phone+1-210-567-4188
Emaillodged@uthscsa.edu

Source: Scopus
Calculated based on no. of publications stored in Pure and citations from Scopus

Research output per year

If you made any changes in Pure these will be visible here soon.

Fingerprint

Dive into the research topics where Daniel J Lodge is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

7 Similar Profiles

Network

Recent external collaboration on country level. Dive into details by clicking on the dots.

2 Finished

Adiponectin regulation of the mesolimbic dopamine system
Lu, X. & Lodge, D. J.
National Institutes of Health
2/22/12 → 1/31/15
Project: Research project
Regulation of ventral hippocampal system function
Lodge, D. J.
National Institutes of Health
7/1/10 → 6/30/20
Project: Research project

3529 Citations
26 h-Index
58 Article
7 Review article
3 Comment/debate
2 Chapter
More
- 1 Editorial

Circuit-Based Interventions for the Treatment of Behaviors Relevant to Schizophrenia
Lodge, D. J., Nov 1 2020, In: Biological Psychiatry. 88, 9, p. 673-674 2 p.
Research output: Contribution to journal › Comment/debate › peer-review
Developmental alterations in the transcriptome of three distinct rodent models of schizophrenia
Donegan, J. J., Boley, A. M., Glenn, J. P., Carless, M. A. & Lodge, D. J., Jun 1 2020, In: PloS one. 15, 6, e0232200.
Research output: Contribution to journal › Article › peer-review

Open Access
Ketamine: Leading us into the future for development of antidepressants
Carreno, F. R., Lodge, D. J. & Frazer, A., Apr 6 2020, In: Behavioural Brain Research. 383, 112532.
Research output: Contribution to journal › Review article › peer-review
4 Scopus citations
Mechanisms associated with the antidepressant-like effects of L-655,708
Bugay, V., McCoy, A. M., Lodge, D. J., Brenner, R., Frazer, A. & Carreno, F. R., Dec 2020, In: Neuropsychopharmacology. 45, 13, p. 2289-2298 10 p.
Research output: Contribution to journal › Article › peer-review
Stem Cells for Improving the Treatment of Neurodevelopmental Disorders
Donegan, J. J. & Lodge, D. J., Sep 1 2020, In: Stem Cells and Development. 29, 17, p. 1118-1130 13 p.
Research output: Contribution to journal › Review article › peer-review
1 Scopus citations

University of Texas Health Science Center-San Antonio: Novel Gene Therapy Curbs Schizophrenia Symptoms
Daniel J Lodge
7/6/19
1 item of Media coverage
Press/Media: Press / Media
University of Texas Health Science Center at San Antonio: Free Public Symposium Nov. 30 to Break Down Schizophrenia's Walls
David A Morilak, Daniel J Lodge & Dawn I Velligan
11/16/18
1 item of Media coverage
Press/Media: Press / Media
Psychiatry's Brave New World--FDA Approves Digital Sensor in Antipsychotic Drug
Daniel J Lodge
1/15/18
1 item of Media coverage
Press/Media: Press / Media
Psychiatry's Brave New WorldFDA Approves Digital Sensor in Antipsychotic Drug to Enforce Prescription Compliance
Daniel J Lodge
1/12/18
1 item of Media coverage
Press/Media: Press / Media
Psychiatry's Brave New World--FDA Approves Digital Sensor in Antipsychotic Drug to Enforce Prescription Compliance
Daniel J Lodge
1/11/18 → 1/12/18
45 items of Media coverage
Press/Media: Press / Media